Advertisement
Pharmacy programs to reduce opioid abuse are effective but underused

Pharmacy Programs to ID Opioid Abuse Effective, but Underused

0
Monitoring program in Maine was only used by 56 percent of pharmacists
The antidepressant escitalopram may not help heart failure patients suffering from depression

Escitalopram Not Beneficial for Heart Failure Patients

0
Depression in heart failure may not be same depression patients without heart failure experience
Certain cancer immunotherapy drugs may increase risk for rheumatic disease

Cancer Immunotherapy May Induce Arthritis, Sicca Syndrome

0
Findings with ipilimumab (anti-CTLA-4) and/or nivolumab (anti-PD-1) for solid tumors
The rate of decline in cardiovascular disease mortality has decelerated

Cardiovascular Disease Mortality Progress Slowing Down in U.S.

0
Mortality rates dropped less than 1 percent from 2011 to 2014
Family-reported quality of end-of-life care is significantly better for patients with cancer or dementia than for patients with other chronic conditions

End-of-Life Care Received Varies Based on Type of Disease

0
Cancer and dementia patients get more access to palliative care
Patients on long-term opioid therapy who receive prescriptions for naloxone are less likely to return for emergency care related to opioid use

Coprescribing Naloxone to Opioid Users Helps Reduce ER Visits

0
Finding supports naloxone prescriptions for patients taking opioids for chronic pain
Patients dying in old age often receive unnecessary end-of-life medical treatments in hospitals

Too Many Elderly, Terminal Patients Getting Unnecessary Tx

0
Doctors, caregivers must be able to better recognize when death is imminent and unavoidable
The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus.

FDA Approves Epclusa for Chronic Hepatitis C

0
Combination drug treats six major strains of hepatitis C virus infection
Experimental studies support the effectiveness of two vaccine candidates against the Zika virus

Two Vaccines Deemed Feasible Against Zika Virus Infection

0
Two candidates provided protection after just one dose; clinical trials planned for later this year
Methylene blue may increase activity in brain regions involved in short-term memory and attention